Valuation: Medpace Holdings, Inc.

Market Cap 18.59B 16.76B 15.48B 14B 26.48B 1,744B 27.14B 186B 73.96B 934B 69.79B 68.3B 2,972B P/E 2026 *
36.5x
P/E 2027 * 33.9x
Enterprise Value 17.78B 16.03B 14.81B 13.39B 25.33B 1,668B 25.95B 177B 70.73B 893B 66.74B 65.32B 2,843B EV / Sales 2026 *
6.24x
EV / Sales 2027 * 5.73x
Free-Float
81.14%
Yield 2026 *
-
Yield 2027 * -
1 day-1.04%
1 week+3.54%
Current month+0.83%
1 month+6.03%
3 months+10.13%
6 months+56.62%
Current year+17.05%
1 week 635
Extreme 635
679.18
1 month 605.76
Extreme 605.76
693.97
Current year 373
Extreme 373
693.97
1 year 373
Extreme 373
693.97
3 years 250.05
Extreme 250.05
693.97
5 years 126.94
Extreme 126.945
693.97
10 years 21.76
Extreme 21.76
693.97
Manager TitleAgeSince
Chief Executive Officer 69 30/06/1992
Director of Finance/CFO 51 31/07/2021
Chief Tech/Sci/R&D Officer 65 31/08/2017
Director TitleAgeSince
Chairman 69 30/06/1992
Director/Board Member 55 30/06/2016
Director/Board Member 72 30/06/2016
Date Insider Type Main position Quantity % Market Cap. Importance
29/10/26 Sell

Compliance Officer

-1,245 0.0045%
27/10/26 Sell

Chief Operating Officer

-3,940 0.0141%
21/10/26 Exercice

Chief Operating Officer

5,400 0.0193%
Change 5-day change 1-year change 3-year change Capi.($)
-0.82%+3.54%+10.01%+138.31% 18.59B
+1.10%+1.03%+62.53%+70.47% 67.53B
+1.28%+8.71%+13.96%+92.70% 60.74B
+0.50%-0.98%+20.05%+98.39% 55.66B
+0.10%+8.62%+11.44%+111.54% 47.97B
-1.14%+2.22%+22.58%+39.80% 45.24B
-1.39%+0.16%+170.29%+805.50% 39.08B
+1.21%+4.75%+27.30%+52.81% 35.34B
-0.87%-2.89%+79.60%+56.33% 33.45B
-1.83%+9.25%-38.88%+397.15% 26.49B
Average -0.25%+2.55%+37.89%+186.30% 43B
Weighted average by Cap. +0.01%+2.81%+39.98%+165.87%

Financials

2026 *2027 *
Net sales 2.85B 2.57B 2.37B 2.15B 4.06B 267B 4.16B 28.44B 11.33B 143B 10.69B 10.47B 456B 3.02B 2.72B 2.52B 2.27B 4.3B 283B 4.41B 30.15B 12.02B 152B 11.34B 11.1B 483B
Net income 521M 469M 433M 392M 741M 48.82B 760M 5.19B 2.07B 26.15B 1.95B 1.91B 83.21B 554M 499M 461M 417M 789M 51.94B 808M 5.53B 2.2B 27.82B 2.08B 2.03B 88.52B
Net Debt -812M -732M -676M -611M -1.16B -76.13B -1.18B -8.1B -3.23B -40.77B -3.05B -2.98B -130B -1.27B -1.15B -1.06B -958M -1.81B -119B -1.86B -12.7B -5.06B -63.91B -4.77B -4.67B -203B
Projected Income Statement - Annual - Medpace Holdings, Inc.
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,600
Date Price Change Volume
12/11/26 US$659.02 -0.87% 52,944
11/11/26 US$664.77 +0.03% 134,532
10/11/26 US$664.54 -1.25% 165,203
09/11/26 US$672.93 +3.03% 219,169
06/11/26 US$653.11 +2.86% 231,625
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Medpace Holdings, Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
664.77USD
Average target price
651.31USD
Spread / Average Target
-2.03%
  1. Stock Market
  2. Stocks
  3. MEDP Stock